Skip to content

To compare 7 days vs 14 days of antibiotics in neonatal bacterial infections.

Comparison of Effectiveness of 7 days vs 14 days course of intravenous antibiotics in the treatment of uncomplicated Neonatal Bacterial Sepsis A Randomized controlled noninferiority trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/08/044933
Enrollment
120
Registered
2022-08-25
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P369- Bacterial sepsis of newborn, unspecified

Interventions

Intervention1: Short course antibiotics: Mostly started with IV Ampicillin and @100-150mg/kg/day divided in 2 or 3 doses depending upon age and weight and IV Amikacin @15-18mg/kg given once in 24,36 o

Sponsors

AIIMS Raipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Neonates aged 0-28days, who are currently admitted to the neonatal unit of AIIMS RAIPUR. 2.Birth weight >1000g 3.Suspected septicemia for which a blood culture is sent and for which the treating clinician decides to start antibiotics

Exclusion criteria

Exclusion criteria: 1.Central Nervous System infection (meningitis will be defined as one or more cerebrospinal fluid (CSF) cell count >25 microliters with >60% neutrophils: glucose 150 mg/dl in term or >180mg/dl in preterm or positive gram stain report or positive report culture. 2.Septic arthritis, osteomyelitis, or deep-seated abscess as clinically judged by the treating team 3.Life-threatening congenital malformations as judged by the principal investigator of the center.

Design outcomes

Primary

MeasureTime frame
Definite or probable relapse. Definite relapse is defined as the occurrence of an episode of illness within the 21 days after antibiotic completion in which the same organism with a similar antibiogram is grown as the original episode. Probable relapse is defined as the occurrence of an episode of illness within 21 days, when an episode is diagnosed to be a relapse of bacterial sepsis based on clinical features and investigations, in the setting of sterile blood culture. Probable relapse is adjudicated by a blinded pediatrician/neonatologist who is not associated with the rest of the study.Timepoint: 21days

Secondary

MeasureTime frame
Definate or probable relapse within 21 or 28 days after antibiotic completion , 2. Definate or probable relapse 28 or 35 days after randomization.Timepoint: 28 or 35 days after randomization.

Countries

India

Contacts

Public ContactDr Ayushie Jain

AIIMS Raipur

atul.jindal@aiimsraipur.edu.in8224014667

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026